Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20011 AL 20025

Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease

Borroni B, Costanzi C, Padovani A.

Curr Alzheimer Res. 2010 Mar;7(2):158-64. doi: 10.2174/156720510790691173.

Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort

Arbus C, Gardette V, Bui E, Cantet C, Andrieu S, Nourhashémi F, Schmitt L, Vellas B; REAL.FR Group.

Int Psychogeriatr. 2010 Feb;22(1):120-8. doi: 10.1017/S1041610209990780. Epub 2009 Sep 7.

The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds

Aprahamian I, Martinelli JE, Neri AL, Yassuda MS.

Int Psychogeriatr. 2010 Feb;22(1):64-71. doi: 10.1017/S1041610209991141. Epub 2009 Oct 9.

Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease

Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):104-10. doi: 10.1016/j.pnpbp.2009.10.007. Epub 2009 Oct 13.

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2

Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D.

J Neurol Sci. 2010 Jan 15;288(1-2):112-6. doi: 10.1016/j.jns.2009.09.022.

[Alzheimer disease, memory and estrogen]

Blanc F, Poisbeau P, Sellal F, Tranchant C, de Seze J, André G.

Rev Neurol (Paris). 2010 Apr;166(4):377-88. doi: 10.1016/j.neurol.2009.07.010.

Dementia diagnostics 2.0--transfer from research studies into routine clinical practice

Otto M.

Clin Chem. 2010 Feb;56(2):152-3. doi: 10.1373/clinchem.2009.136051. Epub 2009 Nov 2.

The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study

Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K.

J Neurol Sci. 2010 Mar 15;290(1-2):96-101. doi: 10.1016/j.jns.2009.10.022. Epub 2009 Nov 20.

Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography

Ota T, Shinotoh H, Fukushi K, Kikuchi T, Sato K, Tanaka N, Shimada H, Hirano S, Miyoshi M, Arai H, Suhara T, Irie T.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):74-8. doi: 10.1097/WNF.0b013e3181c71be9.

Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial

Sevigny JJ, Peng Y, Liu L, Lines CR.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):119-24. doi: 10.1177/1533317509350298.

The role of positron emission tomography imaging of beta-amyloid in patients with Alzheimer's disease

Xiong KL, Yang QW, Gong SG, Zhang WG.

Nucl Med Commun. 2010 Jan;31(1):4-11. doi: 10.1097/mnm.0b013e32833019f3.

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, Bombois S, Brettschneider J, Fox NC, von Arnim CA, Teunissen C, Pijnenburg Y, Riepe MW, Otto M, Tumani H, Scheltens P, Buee L, Rossor MN.

Exp Neurol. 2010 Jun;223(2):432-8. doi: 10.1016/j.expneurol.2009.11.010. Epub 2009 Dec 11.

Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease

Någren K, Halldin C, Rinne JO.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1575-93. doi: 10.1007/s00259-009-1301-z. Epub 2009 Dec 22.

Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment

Modrego PJ.

J Alzheimers Dis. 2010;21(4):1077-87. doi: 10.3233/jad-2010-100153.

Oral health in Alzheimer's disease: a review

Mancini M, Grappasonni I, Scuri S, Amenta F.

Curr Alzheimer Res. 2010 Jun;7(4):368-73. doi: 10.2174/156720510791162359.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias